NCT02527824 - Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2017

Conditions

Biliary Tract Neoplasm

Interventions

DRUG

Oxaliplatin, Irinotecan, S-1

"Treatment will be delivered every 2 weeks~1. Oxaliplatin 65 mg/m2 iv on day 1~2. Irinotecan 135 mg/m2 iv on day 1~3. S-1 80 mg/m2/day on day1-7"

Trial Locations (1)

Hallym university medical center, Anyang